Shandong Xinhua Pharmaceutical Co Ltd Total Liabilities
Shandong Xinhua Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Shandong Xinhua Pharmaceutical Co Ltd (000756) has total liabilities worth CN¥3.87 Billion CNY (≈ $566.69 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shandong Xinhua Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Total liabilities of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024. This chart illustrates how Shandong Xinhua Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Shandong Xinhua Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Shandong Xinhua Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Xinhua Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Helia Group Ltd
AU:HLI
|
Australia | AU$1.37 Billion |
|
First Financial Corporation Indiana
NASDAQ:THFF
|
USA | $5.50 Billion |
|
Jiangyin Hengrun Heavy
SHG:603985
|
China | CN¥2.57 Billion |
|
Intelbras S.A. - Indústria de Telecomunicação Eletrônica Brasileira
SA:INTB3
|
Brazil | R$2.41 Billion |
|
Shenzhen Asiantime International Construction Co Ltd
SHE:002811
|
China | CN¥1.17 Billion |
|
Hexatronic Group AB
ST:HTRO
|
Sweden | Skr4.70 Billion |
|
Sudarshan Chemical Industries Limited
NSE:SUDARSCHEM
|
India | Rs58.35 Billion |
|
Guilin Seamild Foods Co Ltd
SHE:002956
|
China | CN¥648.37 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Shandong Xinhua Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shandong Xinhua Pharmaceutical Co Ltd (000756) total assets.
Liquidity & Leverage Metrics
Shandong Xinhua Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Shandong Xinhua Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Xinhua Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
The table below shows the annual total liabilities of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.80 Billion ≈ $556.37 Million |
+8.31% |
| 2023-12-31 | CN¥3.51 Billion ≈ $513.68 Million |
-10.34% |
| 2022-12-31 | CN¥3.92 Billion ≈ $572.92 Million |
+6.37% |
| 2021-12-31 | CN¥3.68 Billion ≈ $538.63 Million |
-0.56% |
| 2020-12-31 | CN¥3.70 Billion ≈ $541.67 Million |
+11.31% |
| 2019-12-31 | CN¥3.33 Billion ≈ $486.62 Million |
+6.60% |
| 2018-12-31 | CN¥3.12 Billion ≈ $456.50 Million |
+15.79% |
| 2017-12-31 | CN¥2.69 Billion ≈ $394.25 Million |
+1.92% |
| 2016-12-31 | CN¥2.64 Billion ≈ $386.82 Million |
+5.40% |
| 2015-12-31 | CN¥2.51 Billion ≈ $367.01 Million |
-- |
About Shandong Xinhua Pharmaceutical Co Ltd
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for act… Read more